z-logo
open-access-imgOpen Access
Depletion of microbiome-derived molecules in the host using Clostridium genetics
Author(s) -
ChunJun Guo,
Breanna M. Allen,
Kamir J. Hiam-Galvez,
Dylan Dodd,
Will Van Treuren,
Steven K. Higginbottom,
Kazuki Nagashima,
Curt R. Fischer,
Justin L. Sonnenburg,
Matthew H. Spitzer,
Michael A. Fischbach
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav1282
Subject(s) - clostridia , biology , clostridium , mutant , microbiome , microbiology and biotechnology , metabolite , bacteria , host (biology) , biochemistry , gene , genetics
Clostridial metabolite production The clostridia are Firmicute bacterial commensals commonly found in the mammalian gut. Clostridia produce a range of metabolites that diffuse into the host's circulation and have been difficult to manipulate genetically, but Guoet al. successfully developed a CRISPR-Cas9 deletion system inClostridium sporogenes (see the Perspective by Henke and Clardy). The authors used deletion mutants and mass spectrometry to elucidate clostridial synthesis of several different branched short-chain fatty acids (SCFAs), including isobutyrate, 2-methylbutyrate, and isovalerate. Germ-free mice colonized with mutants incapable of synthesizing SCFAs showed altered immunoglobulin A production. This finding potentially links bacterial SCFA production and host responses to the presence of the clostridia.Science , this issue p.eaav1282 ; see also p.1309

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom